Extractables and Leachables (E&L) Testing

INTRODUCTION The ICH Q3E Extractables and Leachables (E&L) study requirements outline a unified regulatory expectation for evaluating chemical migrants from […]

The ICH Q3E Extractables & Leachables (E&L) Risk Assessment provides a global structure to ensure that materials, components, and manufacturing

ICH Q3E Extractables and Leachables (E&L) Testing Services are essential for showing that packaging materials, device parts, and manufacturing components

INTRODUCTION The ICH Q3E guideline for Extractables and Leachables provides the international standard for evaluating chemical compounds that may migrate

INTRODUCTION Extractables and Leachables (E&L) Testing in the USA vs. Europe: Regulatory Differences is one of the most crucial topics

Introduction Extractables and Leachables Carcinogenicity Testing plays a vital role in protecting patients who rely on modern pharmaceuticals, biopharmaceuticals, and

INTRODUCTION The rise of biologics and advanced therapies—including monoclonal antibodies, gene therapies, and cell-based products—has revolutionized modern medicine. However, these

INTRODUCTION In modern drug development, Extractables and Leachables Testing for NDA/ANDA plays a critical role in ensuring product safety, purity,

Introduction When a leading pharmaceutical manufacturer identified possible nitrosamine leachables in its infusion bag system, ResolveMass Extractables and Leachables Testing